Suchergebnisse

PubPharm (163)

1

Oncodiabetology III. The relationship of antineoplastic therapies and carbohydrate metabolism

enthalten in: Orvosi hetilap | 2022

von Bánhegyi, R. | Veréb, B. | Gazdag, A. | +4

2

Molecular underpinnings of systemic treatment resistance in metastatic castration-resistant prostate cancer

enthalten in: Orvosi hetilap | 2020

von Szarvas, T. | Csizmarik, A. | Nagy, N. | +5

3

Molecular subtype classification of urothelial bladder cancer and its clinical relevance

enthalten in: Orvosi hetilap | 2019

von Szarvas, T. | Oláh, C. | Riesz, P. | +2

4

Benefits of combining chemotherapy with immuno- oncology therapies or "Is it true that chemotherapy destroys the immune system?"

enthalten in: Magyar onkologia | 2019

von Kocsis, J.

5

Adverse events of immune checkpoint inhibitors and their treatment

enthalten in: Magyar onkologia | 2019

von Dienes, T. | Horváth, O. | Géczi, L.

6

An overview of the research of cancer-related cognitive impairment

enthalten in: Orvosi hetilap | 2019

von Ferencz, V. | S Nagy, Z. | Tóth, M.

7

Lipegfilgrastim - long acting G-CSF in prevention of chemotherapy-induced neutropenia

enthalten in: Magyar onkologia | 2018

von Gálffy, G.

8

The role of steroids in oncological practice

enthalten in: Orvosi hetilap | 2017

von Küronya, Z. | Géczi, L. | Gyergyay, F. | +1

9

Targeted treatment of renal cell carcinoma, treatment caused side-effects and side-effect management

enthalten in: Orvosi hetilap | 2017

von Nagyiványi, K. | Géczi, L.

10

Drug therapy of lymphomas

enthalten in: Magyar onkologia | 2017

von Gergely, L.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]